To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Non-small cell lung cancer (NSCLC)
Mouse studies suggest combined inhibition of EGFR and β-catenin could
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury